Skip to main content

Table 4 Descriptive summaries of patient’s for HF data set

From: Assessing survival time of heart failure patients: using Bayesian approach

Patients status

Covariates

Categories

Number of censored (%)

Number of death (%)

Total

Sex

Female

148 (60.41)

68 (41.46)

216 (52.81)

Male

97 (39.59)

96 (58.54)

193 (47.19)

Age

 ≤ 49

98 (40.0)

17 (10.36)

115 (28.12)

49–65

78 (31.84)

53 (32.32)

131 (32.03)

 ≥ 65

69 (28.16)

94 (57.32)

163 (39.85)

Alcohol

No

172 (70.20)

92 (56.10)

264 (64.55)

Yes

73 (29.80)

72 (43.90)

145 (35.45)

Place of residence

Urban

97 (39.59)

47 (28.66)

144 (35.21)

Rural

148 (60.41)

117 (71.34)

265 (64.79)

History of heart failure

New

74 (30.20)

46 (28.05)

120 (29.34)

HF patient before

84 (34.29)

79 (48.17)

163 (39.85)

Medical OPD

87 (35.51)

39 (23.78)

126 (30.81)

Chronic kidney disease

No

224 (91.43)

61 (37.20)

285 (69.68)

Yes

21 (8.57)

103 (62.80)

124 (30.32)

Hypertension

No

203 (82.86)

45 (27.44)

248(60.64)

Yes

42 (17.14)

119 (72.56)

161 (39.36)

Anemia

No

205 (83.67)

62 (37.80)

267 (65.28)

Yes

40 (16.33)

102 (62.20)

142 (34.72)

Diabetes mellitus

Not

204 (83.26)

34 (20.73)

238 (58.19)

Type I

18 (7.35)

38 (23.17)

56 (13.69)

Type II

23 (9.39)

92 (57.0)

115 (28.12)

Etiology of heart failure

IHD

62 (25.31)

20 (12.19)

82 (20.05)

RVHD

47 (19.18)

44 (26.83)

91 (22.25)

Cardiomyopathy

55 (22.45)

42 (25.61)

97 (23.72)

HHD

55 (22.45)

49 (29.88)

104 (25.43)

Others

26 (10.61)

9 (5.49)

35 (8.55)

Smoking cigarette

No

232 (94.69)

74 (45.12)

306 (74.82)

Yes

13 (5.31)

90 (54.88)

103 (25.18)

Treatments taken

Digoxin

48 (19.59)

31 (18.90)

79 (19.32)

Spironolactone

65 (26.53)

34 (20.73)

99 (24.20)

Atorvastatin

62 (25.31)

41 (25.0)

103 (25.18)

Others

27 (11.02)

20 (12.20)

47 (11.49)

Combination ≥ 2

43 (17.55)

38 (23.17)

81 (19.80)

Stages of heart failure

I

58 (23.67)

5 (3.05)

63 (15.40)

II

61 (24.90)

17 (10.37)

78 (19.07)

III

65 (26.53)

52 (31.71)

117 (28.61)

IV

61 (24.90)

90 (54.87)

151 (36.92)

  1. IHD, Ischemic heart disease; RVHD, Rheumatic valvular heart disease; and HHD, Hypertensive heart disease. Source: JUMC, Jimma, Ethiopia; from first January 2016 to first January 2019